enow.com Web Search

Search results

  1. Results from the WOW.Com Content Network
  2. Dapagliflozin - Wikipedia

    en.wikipedia.org/wiki/Dapagliflozin

    The combination drug was approved for medical use in the United States in February 2017, where it also is sold under the brand name Qtern. [ 61 ] [ 62 ] In May 2019, the fixed-dose combination of dapagliflozin, saxagliptin, and metformin hydrochloride as extended-release tablets was approved in the United States to improve glycemic control in ...

  3. Dapagliflozin/saxagliptin - Wikipedia

    en.wikipedia.org/wiki/Dapagliflozin/saxagliptin

    Main page; Contents; Current events; Random article; About Wikipedia; Contact us

  4. SGLT2 inhibitor - Wikipedia

    en.wikipedia.org/wiki/SGLT2_inhibitor

    Sotagliflozin (Inpefa) is a dual SGLT1/SGLT2 inhibitor approved by the US Food and Drug Administration (FDA) in May 2023, to reduce the risk of cardiovascular death, hospitalization for heart failure, and urgent heart failure visit in adults with heart failure or type 2 diabetes, chronic kidney disease, and other cardiovascular risk factors.

  5. What Does This New Diabetes Drug Mean for AstraZeneca ... - AOL

    www.aol.com/news/2014-01-15-new-diabetes-drug...

    Recently, two pharmaceutical giants received FDA approval for a new treatment for type 2 diabetes. Farxiga (dapagliflozin) is a "sodium-glucose co-transporter 2 inhibitor", or SGLT2 inhibitor for ...

  6. 19 drug approvals in 2024 that had 'big clinical impact ... - AOL

    www.aol.com/news/19-drug-approvals-2024-had...

    Here is the list in order of FDA approval date. Read On The Fox News App. 1. Dupixent – Additional use: Eosinophilic esophagitis (an allergic condition that causes inflammation of the esophagus) 2.

  7. AstraZeneca plc (ADR) Hopes Farxiga Can Go Far - AOL

    www.aol.com/2014/01/09/astrazeneca-plc-adr-hopes...

    For premium support please call: 800-290-4726

  8. Dapagliflozin/metformin - Wikipedia

    en.wikipedia.org/wiki/Dapagliflozin/metformin

    Dapagliflozin/metformin was approved for use in the European Union in January 2014, [3] in the United States in February 2014, [5] [6] and in Australia in July 2014. [ 7 ] Adverse effects

  9. AstraZeneca's Farxiga Flunks Late-Stage COVID-19 Study - AOL

    www.aol.com/news/astrazenecas-farxiga-flunks...

    AstraZeneca plc (NASDAQ: AZN) presented detailed data from the DARE-19 Phase 3 trial at the American College of Cardiology, evaluating Farxiga (dapagliflozin) to treat hospitalized COVID-19 ...